BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Press Releases

  American Aires Announces Record Preliminary Q4/2024 Performance & Provides 2025 Guidance

  January 27, 2025

   · 

  16 min read
• Press Releases

  ONCOMATRYX Raises €25 Million to Foster OMTX705 Clinical Trials

  January 27, 2025

   · 

  1 min read
• 

  Press Releases

  Acne Vulgaris Market Size to Reach USD 10.4 Billion by 2035, with a Growth Rate (CAGR) of 3.33% during 2025-2035

  January 27, 2025

   · 

  11 min read
• Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

  January 27, 2025

   · 

  3 min read
• 

  Press Releases

  Ringworm Market Size to Grow at a CAGR of 3.55% during 2025-2035, Impelled by Advancements in Early Detection

  January 27, 2025

   · 

  9 min read
• 

  Press Releases

  Bronchopulmonary Dysplasia Market Size to Reach USD 472.0 Million by 2035, Impelled by Increasing Premature Birth Rates

  January 27, 2025

   · 

  10 min read
• Press Releases

  Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux

  January 27, 2025

   · 

  15 min read
• Press Releases

  Invivyd Provides Another Positive SARS-CoV-2 Variant Data Analysis to Satisfy U.S. FDA’s Gating Request for Completing Its Review of EUA Request for PEMGARDA™ (pemivibart) for the Treatment of Mild-to-Moderate COVID-19 in Certain Immunocompromised Patients

  January 27, 2025

   · 

  14 min read
• Press Releases

  Allakos Announces Topline Results from its Phase 1 Trial of AK006 in Patients with Chronic Spontaneous Urticaria and Announces Restructuring

  January 27, 2025

   · 

  5 min read
• Press Releases

  GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-3650, Second-Generation TriKE for the Treatment of Hematologic Malignancies

  January 27, 2025

   · 

  3 min read